stars 1 stars 2 stars 3

View Cellf Solutions's top competitors like Cynata Therapeutics, Global Medical Discovery Company, and Immutep S.A.

Immutep S.A
Established in 2001, Immutep is headquartered in Sydney, New South Wales. They are a biotechnology company working in the field of cancer immunotherapy.
Sydney, AU
Public
$4M Revenue
http://www.immutep.com
IMMP Ticker
Cynata Therapeutics
Cynata Therapeutics Limited (ASX: CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on Cymerus™, a proprietary therapeutic stem cell platform technology. Cymerus™ overcomes the challenges of other production methods by using induced pluripotent stem cells (iPSCs) and a precursor cell known as mesenchymoangioblast (MCA) to achieve economic manufacture of cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale without the limitation of multiple donors. Cynata’s lead product candidate CYP-001 met all clinical endpoints and demonstrated positive safety and efficacy data for the treatment of steroid-resistant acute graft-versus-host disease (GvHD) in a Phase 1 trial. Clinical trials of Cymerus MSC products in osteoarthritis (Phase 3) and in severe complications arising from COVID-19 (Phase 2) are currently ongoing. Planning is also underway for further clinical trials of Cymerus MSC products in GvHD (through licensee Fujifilm), critical limb ischemia, idiopathic pulmonary fibrosis, renal transplantation, and diabetic foot ulcers. In addition, Cynata has demonstrated utility of its Cymerus MSC technology in preclinical models of numerous diseases, including the clinical targets mentioned above, as well as asthma, heart attack, sepsis, acute respiratory distress syndrome (ARDS) and cytokine release syndrome.
Cremorne, AU
Public
$5.9M Revenue
http://www.cynata.com
6 Employees
CYP Ticker
Global Medical Discovery the World’s leading source of medical research news: featuring the innovations that will lead to a brighter tomorrow. Global Medical Discovery features papers of exceptional scientific importance and intelligible to a broad scientific audience. Global Medical Discovery is viewed almost 700,000 times each month by professors, clinicians and R&D scientists and it is linked to the top 50 biotechnology and pharmaceutical companies as well as major research institutions. Explore Key Scientific Articles highlighted at Global Medical Discovery based on quality and its potential scientific impact: https://globalmedicaldiscovery.com
CA
Private
$5M Revenue
https://globalmedicaldiscovery.com/
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users